Koers Bristol-Myers Squibb Company Swiss Exchange
Aandelen
BMY
US1101221083
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
44,39 CHF | -0,25% | -18,16% | -18,16% |
11:38 | Bristol-Myers Squibb investeert in NeoPhore | MT |
21/05 | Bristol-Myers Squibb zegt dat US FDA actiedatum subcutane Nivolumab opnieuw heeft vastgesteld | MT |
Omzet 2024 * | 46,03 mld. 42,05 mld. 42,44 mld. | Omzet 2025 * | 46,06 mld. 42,08 mld. 42,47 mld. | Marktkapitalisatie | 85,69 mld. 78,28 mld. 79,01 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -5,41 mld. -4,95 mld. -4,99 mld. | Nettowinst (verlies) 2025 * | 10,22 mld. 9,34 mld. 9,42 mld. | EV/omzet 2024 * | 2,72 x |
Nettoschuld 2024 * | 39,31 mld. 35,92 mld. 36,25 mld. | Nettoschuld 2025 * | 32,04 mld. 29,27 mld. 29,54 mld. | EV/omzet 2025 * | 2,56 x |
K/w-verhouding 2024 * |
-16,1
x | K/w-verhouding 2025 * |
8
x | Werknemers | 34.100 |
Dividendrendement 2024 * |
5,69% | Dividendrendement 2025 * |
5,98% | Vrij verhandelbaar | 69,27% |
Recentste transcriptie over Bristol-Myers Squibb Company
1 dag | -0,25% | ||
1 week | -18,16% | ||
Lopende maand | -18,16% | ||
1 maand | -18,16% | ||
3 maanden | -18,16% | ||
6 maanden | -18,16% | ||
Lopend jaar | -18,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 53 | 01-02-15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01-04-16 |
Derica Rice
BRD | Director/Board Member | 59 | 01-09-20 |
Datum | Koers | Variatie |
---|---|---|
21-05-24 | 54,24 | -.--% |
17-05-24 | 54,24 | -.--% |
16-05-24 | 54,24 | -.--% |
15-05-24 | 54,24 | -.--% |
14-05-24 | 54,24 | -.--% |
uitgestelde koers Swiss Exchange, 28 juni 2019 om 17:35 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 723 mld. | |
+31,53% | 598 mld. | |
-3,51% | 364 mld. | |
+19,94% | 331 mld. | |
+5,14% | 288 mld. | |
+16,45% | 244 mld. | |
-4,58% | 208 mld. | |
+10,22% | 210 mld. | |
+9,32% | 169 mld. |